These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 4829021)

  • 1. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 2. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lactulose in the treatment of hepatic (pre)coma].
    Grijm R
    Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
    Capocaccia L; Riggio O
    Hepatology; 1990 Aug; 12(2):368-70. PubMed ID: 2391075
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.
    Orlandi F; Freddara U; Candelaresi MT; Morettini A; Corazza GR; Di Simone A; Dobrilla G; Cavallini G
    Dig Dis Sci; 1981 Jun; 26(6):498-506. PubMed ID: 7016484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode.
    Mann NS; Borkar BB; Narenderan KP; Kadian RS; Mann SK; Martin RL
    Am J Gastroenterol; 1979 Aug; 72(2):141-5. PubMed ID: 38663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of lactulose in portal-systemic encephalopathy.
    Matthews SJ
    Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol.
    Rodgers JB; Kiley JE; Balint JA
    Am J Gastroenterol; 1973 Nov; 60(5):459-65. PubMed ID: 4587191
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the action mechanism of lactulose in hepatic coma--clarification of colon urease activity using C-14 urea in rats].
    Bircher J; Gmünder U; Haemmerli UP; Müller-Duysing W; Bally G; Haemmerli G; Hoffmann K
    Strahlentherapie Sonderb; 1968; 67():330-6. PubMed ID: 5719130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.